Search - tctmd.com

Displaying 1 - 20 of 92

Sort: Relevancy | Date

Presentation THT 2026

Overview of Ongoing Studies with Gene Therapy for Cardiovascular Diseases

Presenter: Joe Rossano

March 03, 2026

Presentation THT 2026

Identifying and Preventing Toxicity

Presenter: Eric D. Adler

March 03, 2026

Presentation THT 2026

Designing Studies for Gene Therapy for Rare Diseases

Presenter: Barry Greenberg

March 03, 2026

Presentation THT 2026

Defining the Targets for Gene Therapy and Optimizing Vectors for Delivery

Presenter: Roger J. Hajjar

March 03, 2026

Presentation THT 2026

LVADs to Jumpstart the Process of Myocardial Regeneration

Presenter: Stavros G. Drakos

March 02, 2026

Presentation THT 2026

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Presenter: Sunjay Kaushal

March 02, 2026

Presentation THT 2026

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Presenter: Eugene Jiaxian Wang

March 02, 2026

Presentation THT 2026

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Presenter: Kathy Ivey

March 02, 2026

Presentation THT 2026

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Presenter: James F. Martin

March 02, 2026

Presentation THT 2026

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Presenter: Eric D. Adler

March 02, 2026

Presentation THT 2026

Overview of Gene Therapies for Specific Cardiomyopathies

Presenter: Barry Greenberg

March 02, 2026

Presentation TCT 2025

Continuous, Non-Invasive Left Ventricular Volume Monitoring for Next-Generation Hemodynamic Monitoring (SensVita)

Presenter: Thomas Conroy

October 27, 2025

Presentation THT 2025

cBIN1 Gene Therapy: Repairing Heart Muscle to Reverse Heart Failure

Presenter: Robin Shaw

February 13, 2025

Presentation THT 2025

Overview of Gene Therapy: Vectors, Modes of Delivery and Immunosuppression

Presenter: Joe Rossano

February 12, 2025

Presentation THT 2025

Gene Therapy to Reverse Acquired Cardiomyopathy and Recover Chronic Heart Failure

Presenter: Robin Shaw

February 12, 2025

Presentation THT 2025

Gene Therapy for Monogenic Disorders: Current and Pending Studies

Presenter: Barry Greenberg

February 12, 2025

Presentation THT 2025

Baroceptor Activation Therapy

Presenter: Shelley Hall

February 12, 2025

Presentation THT 2025

Limited Myocardial Necrosis With Intracoronary Supersaturated Oxygen Therapy in Acute Anterior Myocardial Infarction: Initial Experience in Routine Practice

Presenter: Andreas Schafer

February 12, 2025

Presentation THT 2025

Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial

Presenter: Matteo Pagnesi

February 12, 2025

Presentation THT 2025

A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial

Presenter: Akshay Desai

February 12, 2025

Advertisement

Overview of Ongoing Studies with Gene Therapy for Cardiovascular Diseases

Identifying and Preventing Toxicity

Designing Studies for Gene Therapy for Rare Diseases

Defining the Targets for Gene Therapy and Optimizing Vectors for Delivery

LVADs to Jumpstart the Process of Myocardial Regeneration

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Overview of Gene Therapies for Specific Cardiomyopathies

Continuous, Non-Invasive Left Ventricular Volume Monitoring for Next-Generation Hemodynamic Monitoring (SensVita)

cBIN1 Gene Therapy: Repairing Heart Muscle to Reverse Heart Failure

Overview of Gene Therapy: Vectors, Modes of Delivery and Immunosuppression

Gene Therapy to Reverse Acquired Cardiomyopathy and Recover Chronic Heart Failure

Gene Therapy for Monogenic Disorders: Current and Pending Studies

Baroceptor Activation Therapy

Limited Myocardial Necrosis With Intracoronary Supersaturated Oxygen Therapy in Acute Anterior Myocardial Infarction: Initial Experience in Routine Practice

Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial

A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content